Betamethasone dipropionate and Rabeprazole sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Betamethasone dipropionate (betamethasone dipropionate) and Rabeprazole sodium (rabeprazole sodium). Common drug interactions include infection among females and lung disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Betamethasone dipropionate and Rabeprazole sodium. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Betamethasone dipropionate?

Betamethasone dipropionate has active ingredients of betamethasone dipropionate. It is often used in psoriasis. eHealthMe is studying from 3,318 Betamethasone dipropionate users. Check the latest studies of Betamethasone dipropionate.

What is Rabeprazole sodium?

Rabeprazole sodium has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 15,786 Rabeprazole sodium users. Check the latest studies of Rabeprazole sodium.

On Jul, 06, 2026

16 people who take Betamethasone dipropionate and Rabeprazole sodium together, and have interactions are studied.

Betamethasone dipropionate and Rabeprazole sodium drug interactions.

What are the common drug interactions of Betamethasone Dipropionate and Rabeprazole Sodium, by gender? *:

female:

Infection
Renal failure (kidney dysfunction)
Drug ineffective
Cholangitis (infection of the bile duct)
Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin))
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Abdominal discomfort
Arthralgia (joint pain)
Back pain
Blood pressure diastolic decreased

male:

Lung disorder (lung disease)
Pneumonia
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Drug eruption (adverse drug reaction of the skin)
Dyspnoea (difficult or laboured respiration)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hepatic necrosis (large portions of liver die off due to severe liver disease)
Malignant neoplasm progression (cancer tumour came back)
Melaena (the passage of black, tarry stools)

What are the common drug interactions of Betamethasone Dipropionate and Rabeprazole Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Back pain
Central nervous system necrosis (destruction of central nervous system)
Confusional state
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Dyspnoea (difficult or laboured respiration)
Melaena (the passage of black, tarry stools)
Mouth haemorrhage (bleeding from mouth)
Pyrexia (fever)

40-49:

Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)

50-59:

Infection
Renal failure (kidney dysfunction)
Abdominal discomfort
Acute hepatic failure
Arthralgia (joint pain)
Back pain
Blood pressure diastolic decreased
Blood pressure increased
Contusion (a type of hematoma of tissue in which capillaries)
Depressed mood

60+:

Lung disorder (lung disease)
Pneumonia
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Post procedural complication
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Cholangitis (infection of the bile duct)
Drug ineffective
Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin))
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Acute myocardial infarction (acute heart attack)

What are the existing conditions these people have? *

Insomnia (sleeplessness): 5 people, 31.25%
High Blood Pressure: 4 people, 25.00%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 4 people, 25.00%
Type 2 Diabetes: 2 people, 12.50%
Localised Infection (infection at the single location): 2 people, 12.50%
Drug Eruption (adverse drug reaction of the skin): 2 people, 12.50%
Gastritis (inflammation of stomach): 2 people, 12.50%
Iron Deficiency Anaemia: 2 people, 12.50%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 2 people, 12.50%
Joint Pain: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Betamethasone dipropionate and Rabeprazole sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously